Literature DB >> 7990150

Characterization by cDNA cloning of two new human protein kinases. Evidence by sequence comparison of a new family of mammalian protein kinases.

J Hanes1, H von der Kammer, J Klaudiny, K H Scheit.   

Abstract

Two new human cDNAs, designated phclk2 and phclk3, which have a high identity to the cDNA of the human protein kinase clk, were characterized. Typical features of hclk2 and hclk3 proteins are non-homologous N-terminal regions and the presence of the C-terminal protein kinase domain, which is characteristic for serine/threonine-type kinases. We also identified the differentially spliced forms phclk2(139) and phclk3(152) with deletions of 88 and 97 nt, respectively, which lead to changes in the open reading frames. hclk2(139) and hclk3(152) proteins do not possess a protein kinase domain and are nearly identical to the N-terminal regions of the above-mentioned protein kinases. We verified that differentially spliced variants also exist for hclk1 as well as for a mouse clk protein kinase. It was shown that shorter and longer alternatively spliced mRNAs co-exist in different human tissues. According to Southern analysis, hclk2 and hclk3 appear to be specified by single copy genes. The genes for hclk2 as well as for hclk3 were localized to human chromosomes 1 and 15, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990150     DOI: 10.1006/jmbi.1994.1763

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

Review 1.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

2.  Adipose Tissue CLK2 Promotes Energy Expenditure during High-Fat Diet Intermittent Fasting.

Authors:  Maximilian Hatting; Amy K Rines; Chi Luo; Mitsuhisa Tabata; Kfir Sharabi; Jessica A Hall; Francisco Verdeguer; Christian Trautwein; Pere Puigserver
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

3.  A tyrosine kinase profile of prostate carcinoma.

Authors:  D Robinson; F He; T Pretlow; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.

Authors:  Kun Jiang; Niketa A Patel; James E Watson; Hercules Apostolatos; Eden Kleiman; Olivia Hanson; Masatoshi Hagiwara; Denise R Cooper
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

5.  PK12, a plant dual-specificity protein kinase of the LAMMER family, is regulated by the hormone ethylene.

Authors:  G Sessa; V Raz; S Savaldi; R Fluhr
Journal:  Plant Cell       Date:  1996-12       Impact factor: 11.277

6.  In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.

Authors:  P I Duncan; D F Stojdl; R M Marius; J C Bell
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  Characterization and comparison of four serine- and arginine-rich (SR) protein kinases.

Authors:  O Nayler; S Stamm; A Ullrich
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

8.  Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT controls cell survival after ionizing radiation.

Authors:  Seon Young Nam; Hyung Ho Seo; Hyung Sun Park; Sungkwan An; Ji-Young Kim; Kwang Hee Yang; Cha Soon Kim; Meeseon Jeong; Young-Woo Jin
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

9.  Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).

Authors:  Bryan T Mott; Cordelle Tanega; Min Shen; David J Maloney; Paul Shinn; William Leister; Juan J Marugan; James Inglese; Christopher P Austin; Tom Misteli; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2009-10-03       Impact factor: 2.823

10.  Regulation and substrate specificity of the SR protein kinase Clk/Sty.

Authors:  Jayendra Prasad; James L Manley
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.